William A. Haseltine

Genomic screening is rapidly moving from the margins of medicine into routine care. This creates a moment in which decisions made now will determine whether it prevents disease or amplifies harm.

The era of predictive genomics is rapidly reshaping how we think about disease, risk and lifelong health. Recent advances in whole-genome sequencing have equipped clinicians with insights into our bodies that are more granular and precise than ever before.

As AI becomes more prevalent in education, work and social life, research is increasingly focused on understanding its nuanced effects on core cognitive functions such as memory, attention and creativity

Longevity and disease resistance in humans may soon be transformed by studying and emulating the genetic strategies encoded in nature’s most resilient and long-lived species.

Agentic artificial intelligence is evolving from an advanced tool to something that resembles a living system, capable of reasoning, planning and learning across disciplines.

AI-powered retinal imaging closes healthcare gaps, enables earlier intervention, and reveals new insights into systemic diseases across diverse populations.

Artificial Intelligence, or AI, is now transforming how we detect, prevent and treat illness, promising earlier interventions, smarter therapies and more affordable care for everyone.​

New antiviral drugs in development could offer the strongest line of defense yet against COVID-19 and other coronaviruses, including future strains that have not yet appeared.

Henagliflozin, a diabetes treatment approved in China, may do more than just control blood sugar—it may actually slow biological aging.

New data from a gene therapy trial provide the first credible evidence that the progression of Huntington’s disease may be slowed by a single, targeted intervention.

Long-term remission in multiple myeloma—a blood cancer once considered incurable—is finally becoming a reality. A single infusion of immunotherapy has kept patients healthy for more than five years.

A single one-time gene therapy could free patients with α-thalassemia, a rare and debilitating blood disorder, from the burden of lifelong transfusions.

For centuries, we’ve thought of these changes as part of the "genetic lottery," something we can't control. Science is now revealing that our choices and environments can tip the scales.

New scientific findings reveal that healthy aging may be possible by managing chronic inflammation—a phenomenon now called “inflammaging.”

There has always been a dream that there could be a pill to replace exercise. New research suggests a molecule called betaine may do just that.

New research reveals that metformin’s power may start in the brain, reshaping our understanding of blood sugar control and healthy aging.

Breakthroughs in cell engineering and transplantation are beginning to overcome roadblocks, and these are a significant achievement for regenerative medicine as a whole.

Why does one child with autism speak fluently but struggle socially, while another barely talks yet shows remarkable pattern recognition?

New effort to address rare genetic conditions that dramatically raise the risk of serious mental health challenges, including schizophrenia.

On June 16, Sarepta Therapeutics announced a second patient death following treatment with its gene therapy